Table 2.
Patient | Location | Figure panel | SUVR 30–50 min | ||
---|---|---|---|---|---|
Arrow-indicated area | Contralateral area | Ratio | |||
EPI-1 | FG | Fig. 1A | 2.05 | 1.78 | 15.12 |
EPI-2 | Anterior MTG | Fig. 1B | 1.83 | 1.64 | 11.22 |
HIP and FG | Fig. 1C | 1.81 | 1.76 | 3.30 | |
EPI-3 | FG | Fig. 1D | 2.04 | 1.75 | 16.72 |
MTG | Fig. 1E | 2.35 | 2.23 | 5.05 | |
EPI-4 | MTG | Fig. 1F | 2.40 | 2.04 | 17.56 |
ITG | Fig. 1G | 2.34 | 1.96 | 18.99 | |
EPI-5 | MTG | Fig. 2A | 1.93 | 1.84 | 4.82 |
FG | Fig. 2B | 2.21 | 2.18 | 1.37 | |
Average | 2.10a | 1.91 | 10.46 | ||
SD | 0.21 | 0.19 | 6.49 |
Statistical significance between SUVRs of arrow-indicated area and contralateral area (P = 0.002, paired t-test, n = 9).